Example: Heart Attack

Clinical Trials on Congenital Myotonic Dystrophy

Total 7 results

NCT03692312

Recruiting

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Conditions: Congenital Myotonic Dystrophy
NCT03059264

Recruiting

Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy

Conditions: Congenital Myotonic Dystrophy
NCT02398786

Recruiting

Myotonic Dystrophy Family Registry

Conditions: Myotonic Dystrophy; Congenital Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Dystrophy 2; Dystrophia Myotonica; Dystrophia Myotonica 1; Dystrophia Myotonica 2; Myotonia Dystrophica; Myotonic Dystrophy, Congenital; Myotonic Myopathy, Proximal; PROMM (Proximal Myotonic Myopathy); Proximal Myotonic Myopathy; Steinert Disease; Steinert Myotonic Dystrophy; Steinert's Disease; Myotonia Atrophica
NCT00082108

Recruiting

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Conditions: Myotonic Dystrophy; Facioscapulohumeral Muscular Dystrophy; Muscular Dystrophy; Myotonic Dystrophy Type 1; Myotonic Dystrophy Type 2; Congenital Myotonic Dystrophy; PROMM (Proximal Myotonic Myopathy); Steinert's Disease; Myotonic Muscular Dystrophy
NCT02251457

Completed

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

Conditions: Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1
NCT02858908

Completed

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Conditions: Myotonic Dystrophy 1
NCT01939561

Completed

Lamotrigine as Treatment of Myotonia

Conditions: Dystrophia Myotonica Type 1; Myotonia Congenita; Paramyotonia Congenita; Hyperkalemic Periodic Paralysis; Potassium-Aggravated Myotonia